Patent · US Expired

Heterobiarly derivatives and pharmaceutical compositions thereof

US5418233A · kind A · utility

26Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 1992
Grant dateMay 23, 1995
Priority date
Expiry dateOct 14, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/650905
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Heterobiaryl derivatives of the formula EQU R.sub.1 NH--X.sub.1 --X.sub.2 --X.sub.3 --Y.sub.1 --Y.sub.2 --Y.sub.3 --Y.sub.4 --E (I) wherein PA0 R.sub.1, X.sub.1 to X.sub.3 and Y.sub.1 to Y.sub.4 are as defined herein, the tautomers, stereoisomers and mixtures thereof, and the salts, particularly the physiologically acceptable salts, thereof with organic or inorganic acids or bases. The derivatives have valuable pharmacological properties, such as inhibiting cell-cell aggregation and cell-matrix interactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.